Louvain-la-Neuve, Belgium, March 24th, 2025 – Ion Beam Applications SA (IBA) announces today the launch of a share buyback program, effective as of March 25th, 2025, in application of article 7:215 of the Belgian Companies and Associations Code.
By a decision of the Board of Directors of March 18th, 2025, taken pursuant to the authorization given by the EGM of September 4th, 2023, IBA launched a program to buy back own shares through a mandate given to a market intermediary. This program covers a maximum of 650.000 ordinary shares. Depending on market conditions, it will be executed over a fixed period of time from March 25th, 2025, to December 31st, 2025 (included). Its objective is to cover the company’s obligation of shares delivery as part of long-term incentive plans granted to management and certain employees in the form of stock options.
IBA will continuously monitor its current and future obligations under its incentive plans in order to maintain an adequate level of treasury shares.
The number of treasury shares held by IBA amounted to 313.579 on March 24th, 2025. The total number of IBA ordinary shares outstanding is 30.282.218.
***ENDS***
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
CONTACT
Olivier Lechien
Corporate Communication Director
+32 10 475 890
[email protected]
Attachment
- 250324-IBA-share buy-back-EN
